Background: Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide, despite gains in diagnostics and treatments made over the last three decades. Existing markers of ovarian cancer possess very limited clinical relevance highlighting the emerging need for identification of novel prognostic biomarkers as well as better predictive factors that might allow the stratification of patients who could benefit from a more targeted approach. Patients and methods: A summary of molecular genetics of EOC. Results: Large-scale high-throughput genomic technologies appear to be powerful tools for investigations into the genetic abnormalities in ovarian tumors, including studies on dysregulated genes and aberrantly activated signaling pathways. Such technologies can complement well-established clinical histopathology analysis and tumor grading and will hope to result in better, more tailored treatments in the future. Genomic signatures obtained by gene expression profiling of EOC may be able to predict survival outcomes and other important clinical outcomes, such as the success of surgical treatment. Finally, genomic analyses may allow for the identification of novel predictive biomarkers for purposes of treatment planning. These data combined suggest a pathway to progress in the treatment of advanced ovarian cancer and the promise of fulfilling the objective of providing personalized medicine to women with ovarian cancer. Conclusions: The understanding of basic molecular events in the tumorigenesis and chemoresistance of EOC together with discovery of potential biomarkers may be greatly enhanced through large-scale genomic studies. In order to maximize the impact of these technologies, however, extensive validation studies are required.

Krzystyniak, J., Ceppi, L., Dizon, D., & Birrer, M. (2016). Epithelial ovarian cancer: The molecular genetics of epithelial ovarian cancer. ANNALS OF ONCOLOGY, 27, i4-i10 [10.1093/annonc/mdw083].

Epithelial ovarian cancer: The molecular genetics of epithelial ovarian cancer

Ceppi L.
Co-primo
Membro del Collaboration Group
;
2016

Abstract

Background: Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide, despite gains in diagnostics and treatments made over the last three decades. Existing markers of ovarian cancer possess very limited clinical relevance highlighting the emerging need for identification of novel prognostic biomarkers as well as better predictive factors that might allow the stratification of patients who could benefit from a more targeted approach. Patients and methods: A summary of molecular genetics of EOC. Results: Large-scale high-throughput genomic technologies appear to be powerful tools for investigations into the genetic abnormalities in ovarian tumors, including studies on dysregulated genes and aberrantly activated signaling pathways. Such technologies can complement well-established clinical histopathology analysis and tumor grading and will hope to result in better, more tailored treatments in the future. Genomic signatures obtained by gene expression profiling of EOC may be able to predict survival outcomes and other important clinical outcomes, such as the success of surgical treatment. Finally, genomic analyses may allow for the identification of novel predictive biomarkers for purposes of treatment planning. These data combined suggest a pathway to progress in the treatment of advanced ovarian cancer and the promise of fulfilling the objective of providing personalized medicine to women with ovarian cancer. Conclusions: The understanding of basic molecular events in the tumorigenesis and chemoresistance of EOC together with discovery of potential biomarkers may be greatly enhanced through large-scale genomic studies. In order to maximize the impact of these technologies, however, extensive validation studies are required.
Articolo in rivista - Articolo scientifico
Biomarkers; Clinical trials; Genomics; Ovarian cancer;
Biomarkers; Clinical trials; Genomics; Ovarian cancer; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Female; Gene Expression; Humans; Kaplan-Meier Estimate; Molecular Biology; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Squamous Intraepithelial Lesions of the Cervix
English
i4
i10
Krzystyniak, J., Ceppi, L., Dizon, D., & Birrer, M. (2016). Epithelial ovarian cancer: The molecular genetics of epithelial ovarian cancer. ANNALS OF ONCOLOGY, 27, i4-i10 [10.1093/annonc/mdw083].
Krzystyniak, J; Ceppi, L; Dizon, D; Birrer, M
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/269746
Citazioni
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 37
Social impact